These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 5128419)

  • 1. Haloperidol.
    Inglis W
    Med J Aust; 1971 Dec; 2(26):1344. PubMed ID: 5128419
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter: Haloperidol, thyrotoxicosis, and neurotoxicity.
    Hamadah K; Teggin AF
    Lancet; 1974 Oct; 2(7887):1019-20. PubMed ID: 4138314
    [No Abstract]   [Full Text] [Related]  

  • 3. Toxicological studies on haloperidol.
    Seay PH; Field WE
    Int J Neuropsychiatry; 1967 Aug; 3():Suppl 1:19-21. PubMed ID: 6069313
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical application of the concept of relative potency: an example involving chlorpromazine and haloperidol.
    Preskorn SH
    J Psychiatr Pract; 2005 Jul; 11(4):258-61. PubMed ID: 16041236
    [No Abstract]   [Full Text] [Related]  

  • 5. The neuroleptic activity of haloperidol increases after its solubilization in surfactant micelles. Micelles as microcontainers for drug targeting.
    Kabanov AV; Chekhonin VP; Alakhov VYu ; Batrakova EV; Lebedev AS; Melik-Nubarov NS; Arzhakov SA; Levashov AV; Morozov GV; Severin ES
    FEBS Lett; 1989 Dec; 258(2):343-5. PubMed ID: 2599097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroleptic-induced parkinsonism increases with repeated treatment in monkeys.
    Casey DE
    Psychopharmacol Ser; 1987; 3():243-7. PubMed ID: 3823091
    [No Abstract]   [Full Text] [Related]  

  • 7. Hyperactive behavioural effects induced by intranigral infusion of a pyridinium metabolite of haloperidol in rats.
    Fang J
    Can J Physiol Pharmacol; 1996 Dec; 74(12):1359-61. PubMed ID: 9047047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacology and biochemistry of haloperidol.
    Niemegeers CJ; Laduron PM
    Proc R Soc Med; 1976; 69 suppl 1(Suppl 1):3-8. PubMed ID: 14331
    [No Abstract]   [Full Text] [Related]  

  • 9. Oral administration of haloperidol at clinically recommended doses elicits smaller parkinsonian effects but more tardive dyskinesia in rats.
    Shireen E; Naeem S; Inam QU; Haleem DJ
    Pak J Pharm Sci; 2013 Mar; 26(2):271-6. PubMed ID: 23455196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of single prenatal haloperidol exposure on hippocampus and striatum of developing rat brain.
    Singh KP; Singh M
    Indian J Exp Biol; 2001 Mar; 39(3):223-9. PubMed ID: 11495280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-administration of progabide inhibits haloperidol-induced oral dyskinesias in rats.
    Kaneda H; Shirakawa O; Dale J; Goodman L; Bachus SE; Tamminga CA
    Eur J Pharmacol; 1992 Feb; 212(1):43-9. PubMed ID: 1555638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Collaborative work to determine an optimal administration period and optimal parameters for detection of effects on male fertility in rats--male reproductive toxicity study of haloperidol.
    Imanishi M; Yoneyama M; Takagi S; Takeuchi M
    J Toxicol Sci; 1995 Aug; 20(3):297-307. PubMed ID: 8667454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic treatment of haloperidol induces pathological changes in striatal neurons of guinea pigs: a light and electron microscopical study.
    Altunkaynak BZ; Ozbek E; Unal B; Aydin N; Aydin MD; Vuraler O
    Drug Chem Toxicol; 2012 Oct; 35(4):406-11. PubMed ID: 22309399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morphological changes in rat striatal boutons after chronic methamphetamine and haloperidol treatment.
    Ihara Y; Sato M; Otsuki S; Kaiya H; Namba M
    Neurosci Res; 1986 Jul; 3(5):403-10. PubMed ID: 3748472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haloperidol-stomach lesions attenuation by pentadecapeptide BPC 157, omeprazole, bromocriptine, but not atropine, lansoprazole, pantoprazole, ranitidine, cimetidine and misoprostol in mice.
    Bilic I; Zoricic I; Anic T; Separovic J; Stancic-Rokotov D; Mikus D; Buljat G; Ivankovic D; Aralica G; Prkacin I; Perovic D; Mise S; Rotkvic I; Petek M; Rucman R; Seiwerth S; Sikiric P
    Life Sci; 2001 Mar; 68(16):1905-12. PubMed ID: 11292068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haloperidol causes cytoskeletal collapse in N1E-115 cells through tau hyperphosphorylation induced by oxidative stress: Implications for neurodevelopment.
    Benítez-King G; Ortíz-López L; Jiménez-Rubio G; Ramírez-Rodríguez G
    Eur J Pharmacol; 2010 Oct; 644(1-3):24-31. PubMed ID: 20621083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The blood concentration and organ distribution of haloperidol at therapeutic and toxic doses in severe fatty liver disease.
    Ikemura M; Nakagawa Y; Shinone K; Inoue H; Nata M
    Leg Med (Tokyo); 2012 May; 14(3):147-53. PubMed ID: 22366175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct endocrine effects of chronic haloperidol or risperidone administration in male rats.
    Lin EJ; Lee NJ; Slack K; Karl T; Duffy L; O'brien E; Matsumoto I; Dedova I; Herzog H; Sainsbury A
    Neuropharmacology; 2006 Dec; 51(7-8):1129-36. PubMed ID: 16919686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emergence of oral and locomotor activity in chronic haloperidol-treated rats following cortical N-methyl-D-aspartate stimulation.
    Grimm JW; Kruzich PJ; See RE
    Pharmacol Biochem Behav; 1998 May; 60(1):167-73. PubMed ID: 9610939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Undernutrition during suckling changes the sensitivity to haloperidol and chlorpromazine in two behavioural measures in weaning rats.
    Rocha JB; Santos JE; Rocha LK; Kleinpaul ER
    Pharmacol Toxicol; 1997 Sep; 81(3):114-23. PubMed ID: 9335068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.